Microenvironment and tumor progression of melanoma: New therapeutic prospectives

被引:33
作者
Botti, Gerardo [1 ]
Cerrone, Margherita [1 ]
Scognamiglio, Giosue [1 ]
Anniciello, Annamaria [1 ]
Ascierto, Paolo Antonio [1 ]
Cantile, Monica [1 ]
机构
[1] Natl Canc Inst Fdn Pascale, I-80131 Naples, Italy
关键词
Melanoma; tumor progression; ECM proteins; immune-cells; MONOCYTE-CHEMOTACTIC PROTEIN-1; INFILTRATING DENDRITIC CELLS; PRIMARY MALIGNANT-MELANOMA; EXTRACELLULAR-MATRIX; DOWN-REGULATION; INTEGRIN ALPHA(V)BETA(3); METASTATIC MELANOMA; TENASCIN-C; MAST-CELLS; IN-VITRO;
D O I
10.3109/1547691X.2012.723767
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Malignant melanoma is a very representative disease in terms of tumor progression processes. During its evolution, a series of events takes place; among these, the cells' 'out-of-control' growth and loss of homeostasis play crucial roles in the genesis of the tumor itself and its subsequent progression. These events involve several molecular mechanisms associated with both melanocyte transformation and changes to/in the surrounding microenvironment. In particular, interactions between transformed cells and between these cells and the local extracellular matrix (ECM) play key roles in melanoma progression. A description of main ECM molecules involved in melanoma tumor progression, of different cell types present in the tumor microenvironment, and the interactions between all these elements, will be discussed in this review. Taking a broad view of the activity of these cells, molecules, and systems and mechanisms that allow for interference with their expression/function could be useful for designing potential combinations of specific target therapies and immunotherapies that could be more efficient approaches against malignant melanoma.
引用
收藏
页码:235 / 252
页数:18
相关论文
共 221 条
[1]  
Abe K, 1998, CANCER IMMUNOL IMMUN, V45, P225
[2]   Fragments of extracellular matrix as mediators of inflammation [J].
Adair-Kirk, Tracy L. ;
Senior, Robert M. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (6-7) :1101-1110
[3]  
Aharinejad Seyedhossein, 2007, Methods Mol Biol, V361, P227
[4]   Anti-inflammatory properties of the novel antitumor agent yondelis (Trabectedin): Inhibition of macrophage differentiation and cytokine production [J].
Allavena, P ;
Signorelli, M ;
Chieppa, M ;
Erba, E ;
Bianchi, G ;
Marchesi, F ;
Olimpio, CO ;
Bonardi, C ;
Garbi, A ;
Lissoni, A ;
de Brand, F ;
Jimeno, J ;
D'Incalci, M .
CANCER RESEARCH, 2005, 65 (07) :2964-2971
[5]   The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages [J].
Allavena, Paola ;
Sica, Antonio ;
Solinas, Graziella ;
Porta, Chiara ;
Mantovani, Alberto .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (01) :1-9
[6]   The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance [J].
Allavena, Paola ;
Sica, Antonio ;
Garlanda, Cecilia ;
Mantovani, Alberto .
IMMUNOLOGICAL REVIEWS, 2008, 222 :155-161
[7]   Melanoma: A model for testing new agents in combination therapies [J].
Ascierto, Paolo A. ;
Streicher, Howard Z. ;
Sznol, Mario .
JOURNAL OF TRANSLATIONAL MEDICINE, 2010, 8
[8]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[9]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[10]   Differential modulation of human melanoma cell metalloproteinase expression by α2β1 integrin and CD44 triple-helical ligands derived from type IV collagen [J].
Baronas-Lowell, D ;
Lauer-Fields, JL ;
Borgia, JA ;
Sferrazza, GF ;
Al-Ghoul, M ;
Minond, D ;
Fields, GB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (42) :43503-43513